Galectin Therapeutics (GALT) vs Relmada Therapeutics (RLMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Relmada Therapeutics (RLMD) has outperformed Galectin Therapeutics (GALT) over the past year, gaining 63.3% versus a loss of 24.1%. Over five years, GALT leads with a +7.4% price change compared with -86.2% for RLMD. Galectin Therapeutics is the larger company by market cap ($365.1 million vs $346.7 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | GALT | RLMD |
|---|---|---|
| Share price | $3.62 | $3.25 |
| Market cap | $365.08M | $346.68M |
| 1-day change | -3.72% | -0.91% |
| YTD return | -12.98% | -32.71% |
| 1-year return | -24.11% | +63.32% |
| 5-year return | +7.42% | -86.25% |
| EPS (TTM) | $-0.43 | $-0.91 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $7.13 | $8.00 |
| 52-week low | $2.03 | $1.80 |
| Distance from 52-week high | -49.23% | -59.38% |
| Average volume | 387.94K | 1.34M |
| Shares outstanding | 100.85M | 106.67M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- RLMD has outperformed GALT by 87.4 percentage points over the past year.
GALT vs RLMD FAQ
Which is bigger, Galectin Therapeutics or Relmada Therapeutics?
Galectin Therapeutics (GALT) is larger, with a market capitalization of $365.08M compared with $346.68M for Relmada Therapeutics (RLMD).
Which stock has performed better over the past year, GALT or RLMD?
RLMD returned +63.32% over the past 12 months, compared with -24.11% for GALT (price return, excluding dividends). Past performance does not predict future results.
Are Galectin Therapeutics and Relmada Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.